Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Martina Bogeljić Patekar"'
Autor:
Martina Bogeljić Patekar, Vibor Milunović, Karla Mišura Jakobac, Dražen Perica, Inga Mandac Rogulj, Marin Kursar, Ana Planinc-Peraica, Slobodanka Ostojić Kolonić
Publikováno v:
Acta Clinica Croatica, Vol 57., Iss 3., Pp 542-553 (2018)
The aim of this review is to present data on bendamustine, a non-cross resistant alkylating agent, alone or in combination for treatment of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Bendamustine is currently approved for ritu
Externí odkaz:
https://doaj.org/article/a532d7dede5040d49da04c819b38aa99
Autor:
Vibor Milunović, Martina Bogeljić Patekar, Karla Mišura Jakubac, Inga Mandac Rogulj, Delfa Radić-Krišto, Ana Planinc-Peraica, Slobodanka Ostojić Kolonić
Publikováno v:
Acta Clinica Croatica, Vol 56., Iss 1., Pp 143-156 (2017)
Rituximab is a chimeric monoclonal CD20 antibody used in the treatment of CD20 positive non-Hodgkin lymphomas and has revolutionized treatment approach to these hematologic malignancies in the last decade. The main aim of this review is to present da
Externí odkaz:
https://doaj.org/article/56a6185676fe49db91e004668b948a8e
Autor:
Vibor Milunović, Inga Mandac Smoljanović, Martina Bogeljić Patekar, Viktor Zatezalo, Marin Kursar, Delfa Radić-Krišto, Slobodanka Ostojić Kolonić, Slavko Gašparov
Publikováno v:
Current Oncology Reports.
Purposeof review: The main aim of this review is to summarize first-line therapy of nodal T-cell non-Hodgkin lymphoma. Recent findings: Current treatment with CHOP chemotherapy results in poor outcomes in the majority of patients. However, there are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe2ae5ed061c188ac2bbf4f89d786bb
https://doi.org/10.1007/s11912-023-01400-w
https://doi.org/10.1007/s11912-023-01400-w
Autor:
Karla Mišura Jakobac, Ana Planinc-Peraica, Marin Kursar, Inga Mandac Rogulj, Dražen Perica, Vibor Milunović, Martina Bogeljić Patekar, Slobodanka Ostojić Kolonić
Publikováno v:
Acta Clinica Croatica
Acta Clinica Croatica, Vol 57, Iss 3., Pp 542-553 (2018)
Acta Clinica Croatica, Vol 57, Iss 3., Pp 542-553 (2018)
SUMMARY – The aim of this review is to present data on bendamustine, a non-cross resistant alkylating agent, alone or in combination for treatment of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Bendamustine is currently appro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a7f03372b0f4055f73828f05fafe24c
https://doi.org/10.20471/acc.2018.57.03.18
https://doi.org/10.20471/acc.2018.57.03.18
Autor:
Martina Bogeljić Patekar, Vibor Milunović, Karla Mišura Jakobac, Dražen Perica, Inga Mandac Rogulj, Marin Kursar, Ana Planinc-Peraica, Slobodanka Ostojić Kolonić
Publikováno v:
Acta clinica Croatica
Volume 57.
Issue 3.
Volume 57.
Issue 3.
The aim of this review is to present data on bendamustine, a non-cross resistant alkylating agent, alone or in combination for treatment of non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Bendamustine is currently approved for ritu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::aad5ca23ab7ca79428ebc324897596b2
https://www.bib.irb.hr/1089253
https://www.bib.irb.hr/1089253
Autor:
Ana Planinc-Peraica, Slobodanka Ostojić Kolonić, Inga Mandac Rogulj, Vibor Milunović, Karla Mišura Jakubac, Delfa Radić-Krišto, Martina Bogeljić Patekar
Publikováno v:
Acta Clinica Croatica, Vol 56., Iss 1., Pp 143-156 (2017)
Rituximab is a chimeric monoclonal CD20 antibody used in the treatment of CD20 positive non-Hodgkin lymphomas and has revolutionized treatment approach to these hematologic malignancies in the last decade. The main aim of this review is to present da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f944ea1807a37d155a3fff764d3a6311
https://pubmed.ncbi.nlm.nih.gov/29120553
https://pubmed.ncbi.nlm.nih.gov/29120553
Autor:
VIBOR MILUNOVIĆ, MARTINA BOGELJIĆ PATEKAR, NIKOLA ZAGORAC, DRAŽEN PERICA, INGA MANDAC ROGULJ, IKA KARDUM-SKELIN, ANA PLANINC-PERAICA, SLOBODANKA OSTOJIĆ KOLONIĆ
Publikováno v:
Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske
Volume 71
Issue 1
Volume 71
Issue 1
Cilj ovog rada bio je prikazati rezultate liječenja bolesnika s relapsnim ili refraktornim klasičnim Hodgkinovim limfomom visokodoznom kemoterapijom praćenom autolognom transplantacijom matičnih stanica u jednoj ustanovi. U retrospektivno istraž
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______951::fdeeebab25a9af593ed50f6953d6df1f
https://hrcak.srce.hr/file/272612
https://hrcak.srce.hr/file/272612
Autor:
Vibor, Milunović, Martina Bogeljić, Patekar, Inga Mandac, Rogulj, Ana, Planinc-Peraica, Slobodanka Ostojić, Kolonić
Publikováno v:
Liječnički vjesnik
Volume 138
Issue 11-12
Volume 138
Issue 11-12
Limfom plaštene zone (engl. Mantle cell lymphoma – MCL) četvrti je najučestaliji ne-Hodgkinov limfom. Karakteriziran je agresivnim tokom s multiplim relapsima. Cilj je rada literaturnim pregledom opisati suvremeni pristup liječenju ovog limfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::01978ef80e8abf7e122c831a79a8f0a3
https://hrcak.srce.hr/173555
https://hrcak.srce.hr/173555
Autor:
Vibor, Milunović, Martina Bogeljić, Patekar, Vinko, Roso, Viktor, Zatezalo, Bojana Aćamović, Stipinović, Karla Mišura, Jakobac, Njetočka Gredelj, Šimec, Delfa, Radić-Krišto, Ana, Planinc-Peraica, Slobodanka Ostojić, Kolonić
Publikováno v:
Liječnički vjesnik
Volume 137
Issue 9-10
Volume 137
Issue 9-10
Autologna transplantacija perifernih matičnih stanica zlatni je standard u liječenju refraktornog ili relapsnoga kemosenzitivnog difuznog B-velikostaničnog limfoma u pogodnih bolesnika. Cilj je ovog rada prikazati ishode autologne transplantacije
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f845ec84d9327823714f041354d3cf5e
https://hrcak.srce.hr/172718
https://hrcak.srce.hr/172718